ConductScience.org, home

Gene · 2646

Papers2,346

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 2,346

Download this page as JSON
TitleJournalYearPMIDFound bySource
Genetically proxied glucokinase activation and risk of diabetic complications: Insights from phenome-wide and multi-omics mendelian randomization.Diabetes Res Clin Pract202540374125PubTator, text miningPubMed
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.J Hepatol202540334848PubTator, text miningPubMed
METTL3 mediates atheroprone flow-induced glycolysis in endothelial cells.Proc Natl Acad Sci U S A202540327688PubTator, text miningPubMed
Genetic Variations in GCKR and PNPLA3 Regulate Metabolic Balance Across the Liver.Diabetes202540272879PubTator, text miningPubMed
Genetic variants associated with metabolic dysfunction-associated fatty liver diseases in a Korean population.Eur J Med Res202540264238PubTator, text miningPubMed
Gene clusters linked to insulin resistance identified in a genome-wide study of the Taiwan Biobank population.Nat Commun202540229288PubTator, text miningPubMed
GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non-Obese Patients With MASLD and Hyperuricemia.Kaohsiung J Med Sci202540202351PubTator, text miningPubMed
Sugar-sensing swodkoreceptors and swodkocrine signaling.Animal Model Exp Med202540110750PubTator, text miningPubMed
Exploration of Circadian Clock-Related Genes in the Pathogenesis of Psoriatic Arthritis to Identify Potential Therapeutic Targets From Multi-Omics Insight: A Mendelian Randomization Study.Int J Rheum Dis202540062439PubTator, text miningPubMed
Revisiting the causal impact of lipid traits on metabolic dysfunction-associated fatty liver disease: Insights from a multidimensional plasma lipid profile.J Diabetes Investig202540052234PubTator, text miningPubMed
Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD).J Clin Exp Hepatol202539926026PubTator, text miningPubMed
Genome-wide association study of the fatty liver index in the Taiwanese population reveals shared and population-specific genetic risk factors across ethnicities.Cell Biosci202539923089PubTator, text miningPubMed
Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study.J Diabetes202539921581PubTator, text miningPubMed
Exploring genetic structures and shared sites between alcohol, cheese intake, and inflammatory bowel disease.Front Nutr202539917747PubTator, text miningPubMed
Effects of coding variants in the glucokinase regulatory protein gene on hepatic glucose and triglyceride metabolism suggest a gene regulatory function of glucokinase.Metabolism202539894388PubTator, text miningPubMed
Genetic insights into visceral obesity with health conditions, from disease susceptibility to therapeutic intervention.Postgrad Med J202539835424PubTator, text miningPubMed
Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.Atheroscler Plus202539802653PubTator, text miningPubMed
Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Gut Liver202539774124PubTator, text miningPubMed
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets.Metabolism202539710002PubTator, text miningPubMed
Dissecting the shared genetic architecture between nonalcoholic fatty liver disease and type 2 diabetes.Hum Mol Genet202539690818PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2646/papers?page=6